ROLE OF PRENATAL ULTRASONOGRAPHY IN WOMEN WITH POSITIVE SCREEN FOR DOWN-SYNDROME ON THE BASIS OF MATERNAL SERUM MARKERS

被引:71
|
作者
NYBERG, DA
LUTHY, DA
CHENG, EY
SHELEY, RC
RESTA, RG
WILLIAMS, MA
机构
[1] UNIV WASHINGTON,DEPT OBSTET & GYNECOL,SEATTLE,WA 98195
[2] SWEDISH MED CTR,MED CTR,CTR PERINATAL STUDIES,SEATTLE,WA
关键词
FETUS; CHROMOSOME ABNORMALITIES; PRENATAL ULTRASONOGRAPHY; PRENATAL DIAGNOSIS; DOWN SYNDROME; ALPHA-FETOPROTEIN; TRIPLE SCREEN;
D O I
10.1016/0002-9378(95)91322-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to evaluate the usefulness of prenatal ultrasonography among women with a positive screen for fetal Down syndrome on the basis of three biochemical markers - maternal serum ol-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. STUDY DESIGN: A total of 395 women underwent prenatal ultrasonography at a single institution after being identified as screen positive (midtrimester risk greater than or equal to 1:195) on the basis of triple-marker screening between 15 and 18 weeks. Ultrasonographic findings were compared with the biochemical markers and the eventual fetal outcome for these patients. Ultrasonographic abnormalities that were evaluated included structural defects, nuchal thickening or cystic hygroma, echogenic bowel, cerebral ventricular dilatation, pylectasis, and shortened femur. RESULTS: Among 395 patients, 374 (94.7%) had normal karyotype by genetic amniocentesis (n = 232) or postnatal follow-up (n = 142), 18 (4.5%) proved to have Down syndrome, and three had other karyotypic abnormalities. One or more ultrasonographic abnormalities were found in nine of 18 (50%) with Down syndrome compared to 27 of 377 (7.2%) other fetuses (p < 0.001). Fetuses with abnormal ultrasonography results included three with other chromosome abnormalities and five with nonchromosomal anomalies. An abnormal ultrasonography result increased the risk of Down syndrome by 5.6-fold (25% from 4.5%) and a negative result reduced the risk by 45% (2.5% from 4.5%). The value of ultrasonography is further enhanced when all chromosome abnormalities and nonchromosomal anomalies are considered. CONCLUSION: Abnormal ultrasonographic findings increase the risk for Down syndrome, whereas normal findings are less predictive of normalcy. After correction for inaccurate menstrual dates, genetic amniocentesis should be offered in spite of a normal ultrasonography result among women with positive triple screen.
引用
收藏
页码:1030 / 1035
页数:6
相关论文
共 50 条
  • [31] Development of medians generators for the calculation of MoM for the first-trimester Down syndrome maternal serum markers
    Morin, Jean-Francois
    Moineau, Marie-Pierre
    Richard-Gireme, Anouk
    Talon, Helene
    ANNALES DE BIOLOGIE CLINIQUE, 2016, 74 (03) : 293 - 298
  • [32] MATERNAL SERUM DOWN-SYNDROME SCREENING - FREE BETA-PROTEIN IS A MORE EFFECTIVE MARKER THAN HUMAN CHORIONIC-GONADOTROPIN
    MACRI, JN
    KASTURI, RV
    KRANTZ, DA
    COOK, EJ
    MOORE, ND
    YOUNG, JA
    ROMERO, K
    LARSEN, JW
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) : 1248 - 1253
  • [33] MATERNAL SERUM SCREENING FOR FETAL DOWN-SYNDROME USING ALPHA-FETOPROTEIN, HUMAN CHORIONIC-GONADOTROPIN, AND UNCONJUGATED ESTRIOL IN ADOLESCENTS
    PHILLIPS, OP
    SHULMAN, LP
    ELIAS, S
    SIMPSON, JL
    ADOLESCENT AND PEDIATRIC GYNECOLOGY, 1993, 6 (02): : 91 - 94
  • [34] A new policy for prenatal screening and diagnosis of Down syndrome for pregnant women with advanced maternal age in a public hospital
    Lo, Tsz Kin
    Lai, Fung King
    Leung, Wing Cheong
    Lau, Wai Lam
    Tang, Lawrence Chang Hung
    Chin, Robert Kien Howe
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2010, 23 (08) : 914 - 919
  • [35] New Down syndrome screening algorithm. Ultrasonographic biometry and multiple serum markers combined with maternal age
    Bahado-Singh, RO
    Oz, AU
    Kovanci, E
    Deren, O
    Copel, J
    Baumgarten, A
    Mahoney, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (06) : 1627 - 1631
  • [36] Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers
    Christiansen, M
    Larsen, SO
    Oxvig, C
    Qin, QP
    Wagner, JM
    Overgaard, MT
    Gleich, GJ
    Sottrup-Jensen, L
    Norgaard-Pedersen, B
    CLINICAL GENETICS, 2004, 65 (01) : 11 - 16
  • [37] Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome
    Christiansen, Michael
    PRENATAL DIAGNOSIS, 2009, 29 (13) : 1249 - 1255
  • [38] Anxiety levels in women undergoing prenatal maternal serum screening for Down syndrome: the effect of a fast reporting system by mobile phone short-message service
    Cheng, Po-Jen
    Wu, Tzong-Lin
    Shaw, Sheng-Wen
    Chueh, Ho-Yen
    Lin, Cheng-Tao
    Hsu, Jenn-Jeih
    Hsieh, T'sang-T'ang
    Soong, Yung-Kuei
    PRENATAL DIAGNOSIS, 2008, 28 (05) : 417 - 421
  • [39] Second-trimester maternal serum inhibin-A screening for fetal Down syndrome in Asian women
    Lam, YH
    Tang, MHY
    PRENATAL DIAGNOSIS, 1999, 19 (05) : 463 - 467
  • [40] First trimester maternal serum screening using biochemical markers PAPP-A and Free β-hCG for down syndrome, patau syndrome and edward syndrome
    Shiefa S.
    Amargandhi M.
    Bhupendra J.
    Moulali S.
    Kristine T.
    Indian Journal of Clinical Biochemistry, 2013, 28 (1) : 3 - 12